Summary of Findings: UsAgainstAlzheimer’s A-LIST Survey on Medicare (CMS) Coverage Decision February 7, 2022 UsAgainstAlzheimer’s fielded a survey, January 27-February 2, 2022, with responses from 752 people who were diagnosed with Mild Cognitive Impairment (MCI)/Alzheimer’s disease (AD) or another dementia, ‘at risk’ for diagnosis, current/former caregivers and those interested in brain health Key overall findings include: 2/3 of respondents were unaware (43%) or unsure (20%) of the CMS decision Of the group that was aware of the CMS decision, few respondents were able to articulate a full awareness of the implications in an open-ended response; many of those respondents were
